Axon Enterprise to Raise $1 Billion Through Convertible Note Offering

The company intends to allocate a portion of the net proceeds toward capped call transactions designed to mitigate potential dilution of its common stock. Remaining funds are earmarked for general corporate purposes, including strategic investments, product development, and future acquisitions. The notes will be senior, unsecured obligations and will not bear regular interest, maturing in September 2031 unless redeemed or converted earlier.

Axon has tapped a consortium of financial institutions to manage the offering, including Goldman Sachs, Morgan Stanley, J.P. Morgan, RBC Capital Markets, and Citigroup. The specific conversion rates and pricing terms remain subject to market conditions. As part of the hedging strategy, the option counterparties may engage in derivative transactions or open-market purchases of Axon stock, activities that could influence the market price of the company's shares during the offering period.